KALV: KalVista Pharmaceuticals Inc

KALV新闻

• Seeking Alpha 09:02 KalVista's EKTERLY Faces Shrinking Market, Oral Competitor Threat (Downgrade) (KALV)
• Investing 12:32 European regulator recommends approval of first oral HAE treatment
• Investing 08:59 Kalvista Pharmaceuticals stock maintains Market Outperform rating at JMP
• Investing 09:05 JMP reiterates Market Outperform rating on Kalvista stock after UK approval
• Investing 20:12 UK approves first oral treatment for hereditary angioedema attacks
• Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
• Benzinga 12:14 Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), Above Food Ingredients (NASDAQ:ABVE)
• Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
• Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
• Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
• Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
• Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
• Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
• Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
• Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
• Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
• Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
• Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
• Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
• Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
• Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
• Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
• Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
• Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment